Author

Z.E. Kemp

Observed names: Z Kemp, Z. Kemp, Zoe Kemp

Institutions: National Health Service, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital

Observed institutions: National Health Service, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital

OpenAlex ID: A5124096763

Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial

2026 · John Burn, Gillian M Borthwick, et al. · The Lancet. Gastroenterology & hepatology · 3

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathway

2026 · Bethany Torr, Lea Mansour, et al. · npj Breast Cancer

485P Review of dosing and scheduling adjustments in patients receiving trastuzumab deruxtecan for metastatic breast cancer in a real-world setting

2026 · C. Chan, I.M. Browne, et al. · ESMO Open

466P Determinants of survival in breast cancer leptomeningeal disease: Experience from a specialized cancer centre

2026 · M. Esteban García, H.C. Wong, et al. · ESMO Open

365P Surgical decision making in the BRCA-direct NHS transformation programme

2026 · S. Bezzaa, R. O'Connell, et al. · ESMO Open

507P Determinants of long-term chemo-immunotherapy benefit in advanced triple-negative breast cancer

2026 · I.M. Browne, C. Chan, et al. · ESMO Open

477P Real-world efficacy and toxicity of capivasertib in metastatic breast cancer: A single-centre retrospective analysis

2026 · C. Chan, I.M. Browne, et al. · ESMO Open

Abstract PD4-07: Association between age at diagnosis and survival among young BRCA carriers with breast cancer: results from an international multicenter hospital-based cohort study

2026 · E. Blondeaux, A. Meacci, et al. · Clinical Cancer Research

O3 Utilising nationally collected data to identify and retrospectively offer germline genetic testing for people diagnosed historically with breast and ovarian cancer: BRCA-DIRECT-RETROSPECTIVE

2026 · Bethany Torr, S Allen, et al.

Adenoid Cystic Carcinoma of the Breast: Clinicopathological Features and Long-Term Outcomes from a 20-Year Retrospective Cohort

2026 · Iseult M. Browne, Susanna Slater, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Works count: 10

Citation count: 3

H-index: 1

I10-index: